CLOV vs DXR · rev $1.37B vs P/E 6.5, rev $1.4M
Clover Health Investments Corp (CLOV) versus Daxor Corporation (DXR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
CLOV currently screens at market cap $1.55B. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
Not investment advice. Open the CLOV and DXR stock pages for the full models.
Not investment advice.